Erlotinib as Frontline Treatment for Elderly Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) and Non-Squamous Histology - Results of a Galician Lung Cancer Group (GGCP044/09 Study) Grupo Galego De Cancro De Pulmon (GGCP)

被引：0
|
作者：
Firvidal, J. L. [1 ]
Vazquez, S. [2 ]
Casal, J. [3 ]
Fernandez, A. [1 ]
Varela, S. [2 ]
Villanueva, M. J. [3 ]
Perez, E. [1 ]
Campos, B. [2 ]
Salgado, M. [1 ]
Mel, J. R. [2 ]
机构：
[1] Complexo Hosp Ourense, Orense, Spain
[2] Hosp Lucus Augusti, Lugo, Spain
[3] Univ Vigo, Complexo Hosp, Vigo 36310, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72400-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S619 / S619
页数：1
相关论文
共 50 条
  • [1] Gemcitabine Plus Oral Vinorelbine as Salvage Therapy Treatment for Patients With Advanced Non-small-cell Lung Cancer and Squamous Histology - a Galician Lung Cancer Group Study (GGCP042/09) Grupo Galego De Cancro De Pulmon (GGCP)
    Vazquez, S.
    Villanueva, M. J.
    Firvida, J. L.
    Lazaro, M.
    Campos, B.
    Grande, C.
    Fernandez, A.
    Varela, S.
    Casal, J.
    Perez, E.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S618 - S618
  • [2] ERLOTINIB AS FRONTLINE TREATMENT FOR ELDERLY PATIENTS (P) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): GGCP044/09 STUDY
    Firvida Perez, J. L.
    Vazquez Estevez, S.
    Casal Rubio, J.
    Alonso Bermejo, M.
    Varela Ferreiros, S.
    Villanueva Silva, M. J.
    Afonso Afonso, J.
    Fernandez Calvo, O.
    Areses, K.
    Campos Balea, B.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S71 - S71
  • [3] ERLOTINIB AS FRONTLINE TREATMENT FOR ELDERLY PATIENTS (P) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): GGCP044/09 STUDY
    Firvida, J. L.
    Vazquez, S.
    Casal, J.
    Alonso, M.
    Varela, S.
    Villanueva, M. J.
    Afonso, F. J.
    Fernandez, O.
    Areses, C.
    Campos, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 436 - 436
  • [4] ERLOTINIB AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER AND NON-SQUAMOUS HISTOLOGY: A GALICIAN LUNG CANCER GROUP STUDY (GGCP041/09)
    Vazquez, S.
    Casal, Joaquin
    Firvida, J. L.
    Lazaro, Martin
    Varela, S.
    Jose Villanueva, Maria
    Garcia-Lopez, Jesus
    Campos, Begona
    Grande, C.
    Fernandez, Ovidio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1297 - S1297
  • [5] Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study.
    Firvida Perez, Jose Luis
    Vazquez Estevez, Sergio
    Casal Rubio, Joaquin
    Alonso Bermejo, Miguel
    Varela Ferreiro, Silvia
    Villanueva Silva, Maria Jose
    Afonso Afonso, Francisco J.
    Lazaro Quintela, Martin
    Areses Manrique, Carmen
    Campos Balea, Begona
    Huidobro Vence, Gerardo
    Fernandez Calvo, Ovidio
    Alvarez Gomez, Elena
    Grande Ventura, Carlos
    Fernandez Montes, Ana
    Castro Gomez, Enrique
    Mel Lorenzo, Jose Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC).
    Vazquez Estevez, Sergio
    Villanueva Silva, Maria Jose
    Firvida Perez, Jose Luis
    Lazaro Quintela, Martin
    Varela Ferreiro, Silvia
    Huidobro Vence, Gerardo
    Fernandez Calvo, Ovidio
    Campos Balea, Begona
    Casal Rubio, Joaquin
    Areses Manrique, Carmen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] GGCP041/09: A GALICIAN STUDY OF SECOND-LINE ERLOTINIB IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC)
    Vazquez Estevez, S.
    Villanueva Silva, M. J.
    Firvida Perez, J. L.
    Lazaro Quintela, M.
    Varela Ferreiro, S.
    Huidobro Vence, G.
    Fernandez Calvo, O.
    Campos Balea, B.
    Grande Ventura, C.
    Areses, K.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S67 - S67
  • [8] A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study
    Casal Rubio, J.
    Firvida-Perez, J. L.
    Lazaro-Quintela, M.
    Baron-Duarte, F. J.
    Alonso-Jaudenes, G.
    Santome, L.
    Afonso-Afonso, F. J.
    Amenedo, M.
    Huidobro, G.
    Campos-Balea, B.
    Lopez-Vazquez, M. D.
    Vazquez, S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (03) : 451 - 457
  • [9] A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study
    J. Casal Rubio
    J. L. Fírvida-Pérez
    M. Lázaro-Quintela
    F. J. Barón-Duarte
    G. Alonso-Jáudenes
    L. Santomé
    F. J. Afonso-Afonso
    M. Amenedo
    G. Huidobro
    B. Campos-Balea
    M. D. López-Vázquez
    S. Vázquez
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 451 - 457
  • [10] Gemcitabine/docetaxel (GD) vs gemcitabine/cisplatin (GC) in stage IIIB/IV advanced non-small cell lung cancer (NSCLC):: Grupo gallego de cancer de pulmon (GGCP)
    Vázquez, S
    Casal, J
    Vázquez, F
    Amenedo, M
    Fírvida, J
    Mel, J
    Huidobro, G
    Lázaro, M
    Alonso, G
    Constela, M
    LUNG CANCER, 2005, 49 : S273 - S273
12345